- SAR of 3,4-dihydropyrido[3,2-d]pyrimidone p38 inhibitors.
SAR of 3,4-dihydropyrido[3,2-d]pyrimidone p38 inhibitors.
Development for a class of potent 3,4-dihydropyrido(3,2-d)pyrimidone inhibitors of p38a MAP kinase is described. Modification of N-1 aryl and C-6 arylsulfide in 3,4-dihydropyrido(3,2-d)pyrimidone analogues for the interaction with the hydrophobic pockets in p38 active site is also discussed.